BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-336@pharmaconomics
DTSTAMP:20260707T030626Z
DTSTART;VALUE=DATE:20260213
DTEND;VALUE=DATE:20260214
SUMMARY:IRON CRL — bitopertin
DESCRIPTION:An FDA complete response letter on bitopertin for erythropoietic protoporphyria is in focus around Feb 13\, 2026.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1816736/000119312526073594/iron-ex99_1.htm\n\nTrack it: https://pharmaconomics.com/e/336
URL:https://pharmaconomics.com/e/336
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:IRON catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR